JUST BREATHE Trial
Phase 2
600
about 3.3 years
18+
36 sites in AL, CA, CO +20
What this study is about
This trial is testing a treatment for ARDS, a serious lung condition. Participants will be randomly assigned to receive either a placebo or one of several different treatments.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Cohort A: placebo
- 2.Take Cohort A: vilobelimab
- 3.Take Cohort B: paridiprubart
- +3 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
bevacizumab, vilobelimab
infusion, injection, intravenous
Secondary: Days of hospitalization up to and including Day 28, Improvements in oxygenation measured as change from baseline in PaO2/FiO2 ratio up to and including Day 28 (or discharge, whichever is earlier), Incidence and severity of adverse events (AEs) /adverse event of special interest (AESI) / serious adverse event (SAEs)